Fresenius Medical Care (NYSE: FMS) has completed the purchase of sole Canadian development and distribution rights to the NephroCare software from Cybernius Medical.
NephroCare is a comprehensive renal information system that electronically manages and reports patient data.
“The NephroCare(R) software allows easy access at the patient's bedside to enable point of care charting in the electronic patient record. It can also provide remote access to patient data for care givers and allow patients access to their own information through patient portal links,” Fresenius Medical Care stated.
Fresenius Medical Care has been distributing NephroCare in Canada for ten years.
Juan Sanchez, FMCC President stated: "Owning the NephroCare software clearly supports our vision to be first choice in renal therapies and reflects well on our on-going commitment to the Canadian renal eHealth market."
Fresenius Medical Care is an integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure.